Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Age (years)</td><td align="center">65.9 (53–76)</td></tr><tr><td align="left">Sex</td><td align="center">11 men; 19 women</td></tr><tr><td align="left">BMI</td><td align="center">28.8 (19–38)</td></tr><tr><td align="left">Deformity</td><td align="center">18 apex-left; 12 apex-right</td></tr><tr><td align="left">Cobb Angle</td><td align="center">20.2° (10.1°–42.0°)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Characteristics of thirty patients treated with XLIF.

The Scientific World Journal

tab1

Table 1

Table 1: Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis 